summary
Introduced
01/30/2026
01/30/2026
In Committee
01/30/2026
01/30/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for drug overdose medication.
AI Summary
This bill amends The Controlled Substance, Drug, Device and Cosmetic Act to expand the types of drug overdose medication that emergency medical services providers can administer. Specifically, it adds "nalmefene" to the list of opioid antagonists, which are medications used to reverse the effects of an opioid overdose, alongside naloxone. This change aims to provide emergency responders with more options to save lives in cases of drug overdose and will take effect 60 days after enactment.
Committee Categories
Health and Social Services
Sponsors (13)
Chris Pielli (D)*,
Lisa Borowski (D),
Tim Brennan (D),
Johanny Cepeda-Freytiz (D),
Mary Jo Daley (D),
Roni Green (D),
Liz Hanbidge (D),
Carol Hill-Evans (D),
Jeanne McNeill (D),
Brian Munroe (D),
Jenn O'Mara (D),
Ben Sanchez (D),
Dan Williams (D),
Last Action
Referred to Health (on 01/30/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.palegis.us/legislation/bills/2025/hb2182 |
| BillText | https://www.palegis.us/legislation/bills/text/PDF/2025/0/HB2182/PN2836 |
Loading...